Clinical Trial Update: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy [Phase 2]

View source ↗

Summary

Phase 2 study of abiraterone acetate in chemo-naive metastatic castration-resistant prostate cancer patients with prior diethylstilbestrol exposure has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2020-01-13